Mississippi Passes "Jill's Law" for Cancer Testing

When Ashleigh Parker stood before Mississippi lawmakers to share her cancer story, she knew exactly what was at stake for thousands of future patients.

The Olive Branch resident was diagnosed with stage 4 colon cancer in 2019, a diagnosis that had already spread to her liver and lymph nodes. But biomarker testing changed everything by revealing which treatments would actually work for her specific cancer.

"Biomarker testing showed us chemotherapy was my best treatment path," Parker told the legislature. "It also caught my cancer recurrence."

The testing later detected a small liver lesion, allowing doctors to perform a simple ablation instead of aggressive treatments. Nearly seven years after her diagnosis, Parker remains in remission and thriving.

Her powerful testimony helped push House Bill 565, known as "Jill's Law," to unanimous passage in the Mississippi Senate on March 4. The legislation requires state-regulated insurance plans, including Medicaid, to cover biomarker testing for cancer patients.

The bill is named after Jill Gary Eure, the late wife of State Representative Casey Eure. But it was Parker's advocacy with the American Cancer Society Cancer Action Network that gave the measure its emotional momentum.

Why This Inspires

Biomarker testing represents a shift away from one-size-fits-all cancer treatment to precision medicine. By identifying specific gene mutations or protein expressions, doctors can avoid prescribing expensive chemotherapy that won't work for individual patients.

More than 18,000 Mississippians are expected to receive a cancer diagnosis this year. Without insurance coverage, many patients can't access the testing that could identify their most effective treatment and save critical time in their cancer fight.

Kimberly Hughes, state government relations director for ACS CAN, emphasized that biomarker testing "helps doctors develop a personalized treatment plan" tailored to each patient's unique cancer.

The bill now sits on Governor Tate Reeves' desk awaiting signature. If approved, the mandate would take effect July 1 for health plans entered into or renewed after that date.

Parker's message to lawmakers was simple but urgent: "All Mississippians deserve the same kind of treatment." Her willingness to share her journey transformed a policy proposal into a deeply personal promise to future cancer patients across the state.

Sometimes the most powerful advocacy comes from those who've walked the hardest roads and turned around to light the way for others.